Technology and Data

Dana Krug, Senior Vice President of Cold Chain Fulfillment at Phononic, discussed the role his company’s technology plays in the pharmaceutical industry.

Pharmacists can fill a role for patients, but without technology supporting workflows and reimbursement efforts, challenges will remain.

The partnership’s revolutionary new product is set to premiere at the National Association of Chain Drug Stores’ Total Store Expo in Boston, Massachusetts, kicking off on August 17, 2024.

Researchers tested various text-to-image generation platforms to better understand issues of representation within artificial intelligence.

J.D. Power released a report detailing the change in mail-order and retail pharmacy trends from 2023 to 2024.

The collaboration between Surescripts and DAW Systems leverages Surescripts’ established e-prescribing network, which last year processed 2.5 billion prescriptions from 1.29 million prescribers across the US.

Emporos announced a strategic partnership with InterLink AI to help pharmacists streamline tasks and fill more prescriptions.

The retail pharmacy chain issued an alert to its customers that purchasing data from 2017 to 2018 may have been breached by a third party.

The study’s mixed findings on telehealth for opioid use disorder (OUD) treatment suggest a need for more individualized approaches to care.

At McKesson ideaShare 2024, Andrea Sikora discussed artificial intelligence and how it has gradually been integrated into health care systems.

Nicolette Mathey, PharmD, founder of ATRIUM24 and Dotti CRM, discussed how new technological tools can help pharmacists care for more patients.

The world’s information is at our fingertips, but understanding that information and applying it to patient care still requires a rigorous education.

The APhA urged policy makers to consider these recommendations to avoid further exacerbating effects of the attack on US health systems.

As health care technology advances and cyberattack threats loom large, researchers aimed to assess the effect of ransomware attacks on US health systems.

After 24 weeks of participation in an AI-driven lifestyle coaching program, 78% of all participants achieved a clinically meaningful SBP reduction of 5 mm Hg or greater.

Research exploring the growing role of artificial intelligence (AI) in health care sheds a light on the potential of the technology to improve skin cancer detection and awareness among patients and health care professionals.

Since diabetes technology innovation, combined with strong patient demand, has outpaced current evaluation methods, investigators are calling for new approaches that “keep up with the times.”

The company, which operates 140 care sites across the country, was forced to shut down health systems earlier this week because of the disruption.

Tandem Diabetes Care, Inc has reported 224 injuries associated with a software malfunction in a companion insulin app, leading the company to issue a recall of the technology.

Designs of existing wearables overlook the specific needs of vulnerable populations, hindering their widespread adoption among increasingly interested communities.

The organization has renewed its recommendation of Prescryptive Health’s artificial intelligence pricing system, stating it can help independent pharmacies stay competitive.

Researchers aimed to evaluate the efficacy of the OpenAI technology and offer guidance into its future implementation within health care services.

Digital therapeutics are positioned as front-runners in the increasingly digital future of health care.

See what's trending in pharmacy with a preview the Drug Topics April issue.

As pharmacies continue their rapid adoption of technological tools to improve efficiency, being prepared for cyberattacks is more important than ever.

Drug Topics sat down with Jude Dieterman, CEO of Outcomes, to discuss the value and uniqueness of the company in the pharmacy market, what’s next on the horizon, and the upcoming event.

Ravi Patel, PharmD, MBA, MS, discusses how artificial intelligence can be a benefit to both patients and community pharmacies.

Each year, drug diversion is estimated to cost the US health care system an estimated $70 billion. Outside of these costs, drug diversion poses a significant risk to patient safety and patient’s communities.

Drug Topics was recently joined by Kevin Smith, PharmD from Prescyptive Health to talk about how the landscape of pharmacy changing, how AI and technology are part of that change, and what can be done to repair a broken system.